Related Experiment Video
Updated: Jul 11, 2026
09:03
Murine Corneal Transplantation: A Model to Study the Most Common Form of Solid Organ Transplantation
Published on: November 17, 2014
[Initial experimental study on pig-rhesus corneal xenotransplantation]
Cun Sun1, Zhi-qiang Pan, Ying Jie
1Beijing Tongren Eye Bank, Beijing Tongren Eye Centre, Capital University of Medical Sciences, Beijing 100730, China.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|September 28, 2007
Summary
Glucocorticoids significantly delayed pig-to-rhesus corneal xenograft rejection, extending graft survival from approximately 15 days to over 180 days. This indicates their potential to improve outcomes in corneal xenotransplantation.
Area of Science:
- Ophthalmology
- Immunology
- Transplantation Science
Context:
- Corneal xenotransplantation, using animal corneas for human recipients, faces significant rejection challenges.
- Understanding the immunological mechanisms of rejection is crucial for improving graft survival.
Purpose:
- To characterize the rejection process in pig-to-rhesus monkey corneal xenografts.
- To evaluate the efficacy of glucocorticoid treatment in prolonging xenograft survival.
Summary:
- Pig corneas were grafted into rhesus monkeys, with one group receiving betamethasone (glucocorticoid) and a control group receiving saline.
- Glucocorticoid treatment significantly increased mean graft survival time (182.8 days vs. 15.5 days).
- Histopathology and immune factor analysis revealed reduced inflammation and intact graft endothelium in the steroid-treated group.
Impact:
- Glucocorticoids demonstrate effectiveness in mitigating immune rejection in corneal xenografts.
- This study provides evidence for the potential of glucocorticoid therapy to enhance corneal xenotransplantation success.
- Findings contribute to the development of strategies for overcoming immune barriers in xenotransplantation.
